This detailed analysis examines the Oxandrolone formulation to determine its chemical purity, active compound concentration, and overall quality characteristics. The assessment employs advanced analytical techniques to validate product quality and ensure compliance with pharmaceutical standards for oral anabolic preparations.
ELISA and MS: Enzyme-Linked Immunosorbent Assay provides specific detection and quantification of oxandrolone, while Mass Spectrometry offers precise molecular identification and purity verification through mass-to-charge ratio analysis.
| Parameter | Value |
|---|---|
| Sample Identification | Oxa (Lot# 572839164-PQR-2024) |
| Dosagen | 10mg/tab |
| Manufacturer: | Universal |
| Concentration | 9.69 mg/tab |
| Purity | 96.9 |
| Impurities | < 3.1% |
The analytical assessment reveals that the Oxandrolone formulation exhibits exceptional purity levels at 96.9%, significantly exceeding the specified range for high-quality pharmaceutical preparations. Immunoassay analysis confirmed the presence of the target compound with excellent specificity, while mass spectrometric evaluation showed correct molecular identification with minimal degradation products. Concentration determination demonstrated excellent consistency across multiple tablet samples, indicating superior manufacturing control.
The Oxandrolone formulation substantially exceeds all quality specifications with exceptional purity levels and precise concentration values. The product demonstrates superior manufacturing quality and consistency, establishing it as a premium preparation suitable for therapeutic applications requiring reliable anabolic medications.
